Royal Brompton & Harefield NHS Foundation Trust — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Royal Brompton & Harefield NHS Foundation Trust appears in 79 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials79

Recruiting shown6

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

A Prospective, Observational, Single Centre Study to Assess the Feasibility of the Data Harvested by the Acorai Intracardiac Pressure Monitoring (ICPM) System in Predicting Prognosis in Patients Discharged From Hospital After Treatment for Acute Decompensated Heart FailureNCT06397833 · lead sponsor · 2024-04-29

Coronary Artery Disease in Hearts Donated for TransplantationNCT06528834 · lead sponsor · 2024-09-01

NOT_YET_RECRUITING

Cardiac Cachexia in Advanced Heart FailureNCT06259045 · lead sponsor · 2024-02-25

DIGITAL-HF - Digital Tools in Heart Failure - a Survey of Patient Usage (DIGITAL-HF)NCT05313880 · lead sponsor · 2022-01-04

Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH)NCT04088279 · lead sponsor · 2018-11-19

LVR in Severe Emphysema Using Bronchoscopic Autologous Blood Instillation in Combination With Intra-bronchial ValvesNCT03010449 · lead sponsor · 2017-08-24

Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise TrialNCT03050424 · lead sponsor · 2017-04-01

Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPDNCT03010592 · lead sponsor · 2017-02-06

Lung Volume Reduction Coil Microbiome StudyNCT03010566 · lead sponsor · 2017-01-30

EBUS-TBNA vs Flex 19G EBUS-TBNANCT02592837 · lead sponsor · 2016-05-01

Intrinsic PEEP and Laryngeal Aperture in COPDNCT02437630 · lead sponsor · 2016-04-01

A Pilot Feasibility Study in Recovered Heart FailureNCT02859311 · lead sponsor · 2016-04-01

Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)NCT02286063 · lead sponsor · 2014-08-01

A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe AsthmaticsNCT02270827 · lead sponsor · 2014-06-01

The Effect of CRT on the Hypercapnic Ventilatory ResponseNCT02203383 · lead sponsor · 2014-06-01

The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)NCT02221804 · lead sponsor · 2014-05-01

LV Endocardial Cardiac Resynchronisation TherapyNCT02174289 · lead sponsor · 2014-04-01

Validation of the ApneaScan Algorithm in Sleep Disordered BreathingNCT02204865 · lead sponsor · 2014-03-01

Post-hospitalisation Nutritional Support and Gait Speed in COPDNCT02261350 · lead sponsor · 2014-01-01

Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?NCT02261337 · lead sponsor · 2013-12-01

Partial Left Ventricular Support in Advanced Heart FailureNCT01879670 · lead sponsor · 2013-06-01

Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RTNCT01883037 · lead sponsor · 2013-06-01

Renal Denervation in Heart Failure With Preserved Ejection FractionNCT01840059 · lead sponsor · 2013-04-01

Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary DiseaseNCT01719822 · lead sponsor · 2012-07-01

Fibre Specific Signalling in the Locomotor Myopathy of Chronic Obstructive Pulmonary DiseaseNCT01471587 · lead sponsor · 2011-12-01

Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?NCT01507415 · lead sponsor · 2011-11-01

Cardiac Magnetic Resonance Imaging Guided Left Ventricular Lead PlacementNCT01417624 · lead sponsor · 2011-08-01

Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary DiseaseNCT01515709 · lead sponsor · 2011-04-01

Implementation of Telemonitoring in Chronic Heart or Lung FailureNCT02180919 · lead sponsor · 2010-06-01

Dysfunctional Breathing in Difficult Asthma.NCT00716677 · lead sponsor · 2009-10-01

Minimally Invasive Endoscopy in Diffuse Lung DiseaseNCT00934778 · lead sponsor · 2009-06-01

Catheter Ablation Versus Medical Rate Control for Atrial Fibrillation in Patients With Heart FailureNCT00878384 · lead sponsor · 2009-04-01

Renal Function in Adults With Congenital Heart Disease.NCT00807274 · lead sponsor · 2008-09-01

Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart FailureNCT00832442 · lead sponsor · 2008-08-01

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyNCT00637065 · lead sponsor · 2008-04-01

The Use of Inflammatory Markers to Guide Therapy in Children With Severe AsthmaNCT00262340 · lead sponsor · 2005-12-01

The Early High Risk Period for Patients With Heart FailureNCT00127322 · lead sponsor · 2004-01-01

Rosiglitazone Plaque StudyNCT00123227 · lead sponsor · 2002-10-01

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung CancerNCT07008742 · collaborator · 2025-06-04

Optimising Azithromycin Prevention Treatment in COPD to Reduce ExacerbationsNCT05772013 · collaborator · 2024-03-05

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)NCT06311708 · collaborator · 2023-01-31

AI & Radiomics for Stratification of Lung Nodules After Radically Treated CancerNCT05375591 · collaborator · 2021-10-13

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis StudyNCT05432739 · collaborator · 2021-04-07

Longitudinal Preschool Wheeze Biomarker StudyNCT06237660 · collaborator · 2024-02-01

Therapy to Maintain Remission in Dilated CardiomyopathyNCT06091475 · collaborator · 2023-12-02

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac DysfunctionNCT05880160 · collaborator · 2023-07-14

Optimising Secondary Prevention and Quality of Life in Early Cardiac RehabilitationNCT04781699 · collaborator · 2021-03-19

'Lung Health Check' Biomarker StudyNCT04957433 · collaborator · 2020-09-28

Co-morbidity and Refractory Asthma - UK Severe Asthma RegistryNCT04553276 · collaborator · 2020-08-26

ENROLLING_BY_INVITATION

Lung Nodule Imaging Biobank for Radiomics and AI ResearchNCT04270799 · collaborator · 2020-06-01

Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated CardiomyopathyNCT04957147 · collaborator · 2019-08-01

Heart Function in Patients Assessed for Sleep ApnoeaNCT03226652 · collaborator · 2017-07-24

Feasibility Study of a New Peripheral Oedema Monitor for Heart FailureNCT02993601 · collaborator · 2017-01-15

Stress Echo 2020 - The International Stress Echo StudyNCT03049995 · collaborator · 2016-11-01

Do Heat and Moisture Exchange Mask Reduce EIB and Cough Severity in AsthmaNCT04302610 · collaborator · 2016-09-01

Intelligent Oxygen Therapy During Activities of Daily LivingNCT02683486 · collaborator · 2016-01-01

Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in AsthmaNCT02703467 · collaborator · 2015-08-01

VIdeo Assisted Thoracoscopic Lobectomy Versus Conventional Open LobEcTomy for Lung CancerNCT03521375 · collaborator · 2015-07-01

Exacerbations in Severe Asthma Patients: Mechanisms and BiomarkersNCT02660853 · collaborator · 2015-06-01

Fluctuation of Airway Function in Children With AsthmaNCT02252289 · collaborator · 2014-09-01

Drugs studied in this sponsor's trials

7 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Royal Brompton & Harefield NHS Foundation Trust as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

aminophylline1

bosentan1

budesonide1

ferric carboxymaltose1

hydrocortisone1

prednisolone1

rosiglitazone1

aminophylline RxCUI 689 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial bosentan RxCUI 75207 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial budesonide RxCUI 19831 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ferric carboxymaltose RxCUI 1433693 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial hydrocortisone RxCUI 5492 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial prednisolone RxCUI 8638 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial rosiglitazone RxCUI 84108 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator41

lead sponsor38

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.